ABSTRACTS from 16th International COnference on ... - CRRT Online
ABSTRACTS from 16th International COnference on ... - CRRT Online
ABSTRACTS from 16th International COnference on ... - CRRT Online
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<str<strong>on</strong>g>ABSTRACTS</str<strong>on</strong>g> FROM 17 TH INTERNATIONAL CONFERENCE ON <strong>CRRT</strong>,<br />
SAN DIEGO, FEB 14-17, 2012<br />
Alexander Biro, Hananya Vaknine,<br />
Zipora Matas, Asora Fux, Leticia<br />
Schreiber, M<strong>on</strong>a Boaz, Zvi Burbea, Relu<br />
Cernes, Alexander Briliant, Ze'ev Katzir<br />
Nephrology Institute, E Wolfs<strong>on</strong><br />
Medical Center, Israel , Pathology<br />
Institute, E Wolfs<strong>on</strong> Medical Center,<br />
Israel, Biochemistry Laboratory, E<br />
Wolfs<strong>on</strong> Medial Center, Israel,<br />
Epidemiology Unit, E Wolfs<strong>on</strong> Medical<br />
Center, Israel<br />
Background: Aminoglycosides cause<br />
nephrotoxicity in 1-2% of patients by<br />
generating reactive oxygen species<br />
(ROS), leading to DNA destructi<strong>on</strong> and<br />
activati<strong>on</strong> of poly(ADP-ribose)<br />
Polymerase (PARP). The ensuing<br />
decline in nicotinamide adenine<br />
dinucleotide (NAD) causes diminished<br />
cellular energetic capacity and necrotic<br />
tubular cell death. Methods: The effect<br />
of PARP inhibiti<strong>on</strong> <strong>on</strong> gentamicininduced<br />
nephrotoxicity was studied in 2<br />
female Wistar-Kyoto rats divided into<br />
treatment groups: c<strong>on</strong>trol (no treatment<br />
or PARP-inhibitor-treated [3-amino<br />
benzamine, 3AB]); gentamicin-treated;<br />
and gentamicin+3AB treated. Kidney<br />
functi<strong>on</strong>, protein and gentamicin levels<br />
and urinary trypsin inhibitory activity<br />
(TIA) were measured. Tissue<br />
microscopic examinati<strong>on</strong> and<br />
immunohistochemical study for<br />
Proliferative Cell Nuclear Antigen<br />
(PCNA) were determined.<br />
Results: The following results were<br />
obtained: Urea was 41.±5.8, 88.3±5.3<br />
and 48.5±12.7 mg/dL in c<strong>on</strong>trol,<br />
gentamicin and gentamicin+3AB-treated<br />
rats, respectively (p=.4). Proteinuria was<br />
7.5±2.9 in c<strong>on</strong>trols, 41.2±18.1 in<br />
gentamicin-treated and 17.6±13.9<br />
mg/24-hours in gentamicin+3AB-treated<br />
rats (p=.3). TIA was 528.75±357.9,<br />
1365.±863.7 and 475.±194.4 inhibitory<br />
units/day in c<strong>on</strong>trol, gentamicin and<br />
gentamicin+3AB-treated rats,<br />
respectively (p=.2). The number of<br />
macr<strong>on</strong>uclei per 1mm2 was significantly<br />
higher in gentamicin-treated rats than in<br />
gentamicin+3AB treated rats (218±11.8<br />
vs. 41.7±36.2. p=.4). The number of<br />
PCNA positive nuclei was marginally<br />
significantly higher in the gentamicintreated<br />
rats than in gentamicin+3AB<br />
treated rats (3585±2215.3 vs. to<br />
626.7±236.9, p=.7). C<strong>on</strong>clusi<strong>on</strong>s:<br />
The effect of PARP inhibitor <strong>on</strong> the<br />
bactericidal activity of gentamicin was<br />
assessed, no effect was observed.<br />
This study illustrates that PARP<br />
inhibitor significantly attenuates<br />
gentamicin-induced nephrotoxicity in<br />
rats with no effect <strong>on</strong> its bactericidal<br />
activity.<br />
33. Plasma NGAL Is An Early<br />
Biomarker Of Graft Functi<strong>on</strong>,<br />
Calcineurin Inhibitor<br />
Nephrotoxicity And Tubular<br />
Regenerati<strong>on</strong> In Kidney<br />
Transplantati<strong>on</strong> From Extended<br />
Criteria D<strong>on</strong>ors<br />
Vincenzo Cantaluppi, Michela<br />
Tamagn<strong>on</strong>e, Sergio Dellepiane, Davide<br />
Medica, Ana M Manzi<strong>on</strong>e, Maria<br />
Messina, Federico Figliolini, Luigi<br />
Bianc<strong>on</strong>e, Giovanni Camussi, Giuseppe<br />
P Segol<strong>on</strong>i<br />
University of Turin, San Giovanni<br />
Battista Molinette Hospital<br />
Background: Delayed graft functi<strong>on</strong><br />
(DGF), defined as the need for dialysis<br />
in the first week after kidney<br />
transplantati<strong>on</strong> (KT), has been<br />
increasing for the use of kidneys <str<strong>on</strong>g>from</str<strong>on</strong>g><br />
extended criteria d<strong>on</strong>ors (ECD). Plasma<br />
Neutrophil Gelatinase-Associated<br />
Lipocalin-2 (NGAL) has been proposed<br />
as early biomarker of DGF. Aims: The<br />
aims of this study were to evaluate: 1)<br />
NGAL in 5 patients in the first 24h after<br />
147